You are here

  • Home
  • Online First
  • Correspondence on ‘Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors’ by Musacchio et al

Article info

Article menu

other Versions

Download PDFPDF
Letter
Correspondence on ‘Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors’ by Musacchio et al

Authors

  • Fatma Ferda Verit Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, errahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey PubMed articlesGoogle scholar articles
  • Fuat Demirkiran Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, errahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Fatma Ferda Verit, Department of Gynecologic Oncology, Istanbul Universitesi-Cerrahpasa, Istanbul, Turkey; fverit{at}gmail.com

Citation

Verit FF, Demirkiran F
Correspondence on ‘Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors’ by Musacchio et al
International Journal of Gynecologic Cancer Published Online First: 20 September 2023. doi: 10.1136/ijgc-2023-004943

Publication history

  • Accepted September 6, 2023
  • First published September 20, 2023.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.